Molecules (Mar 2010)

Vitamins and Prostate Cancer Risk

  • Charles Y.F. Young,
  • R. Jeffrey Karnes,
  • Krishna Vanaja Donkena

DOI
https://doi.org/10.3390/molecules15031762
Journal volume & issue
Vol. 15, no. 3
pp. 1762 – 1783

Abstract

Read online

Prostate cancer (PC) is the second most common cancer in men worldwide. Its prevention and treatment remain a challenge to clinicians. Here we review the relationship of vitamins to PC risk. Many vitamins and related chemicals, including vitamin A, retinoids, several B vitamins, vitamin C, vitamin D and vitamin E have shown their anti-cancer activities as anti-oxidants, activators of transcription factors or factors influencing epigenetic events. Although laboratory tests including the use of animal models showed these vitamins may have anti-PC properties, whether they can effectively prevent the development and/or progression of PC in humans remains to be intensively studied subjects. This review will provide up-to-date information regarding the recent outcomes of laboratory, epidemiology and/or clinical trials on the effects of vitamins on PC prevention and/or treatment.

Keywords